In a Potentially Troubling Development for Africa, Sinovac Did Not Perform Well in Early Test Against Omicron Variant

Researchers at the University of Hong Kong (HKU) found that people inoculated with two doses of Sinovac’s COVID-19 vaccine did not produce sufficient detectable levels of antibodies needed to fend off the new highly-infectious Omicron variant.

A third injection did generate some antibodies but researchers cautioned that it is still too early to tell if the extra booster would be enough to prevent infection.

This marketing content will be shown in place of your protected content to anyone who is not allowed to read the post…

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

The post In a Potentially Troubling Development for Africa, Sinovac Did Not Perform Well in Early Test Against Omicron Variant appeared first on The China Africa Project.



source https://chinaafricaproject.com/2021/12/16/in-a-potentially-troubling-development-for-africa-sinovac-did-not-perform-well-in-early-test-against-omicron-variant/

Comments

Popular posts from this blog

China Angry With Japan Over G7 Joint Statement, Labels Accusations as “Hype”

The Growing Influence of Chinese Policing in Africa

Papua New Guinea, Micronesia to Sign Agreement With U.S. as Pacific Island Countries Increasingly Take Sides in Great Power Rivalry